Antonio DiGiandomenico
ORCID: 0000-0003-1745-647XAlso affiliated with AstraZeneca (Netherlands)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial”.
Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer, Galia Rahav +94 more
Lindsay Jackson, Yvonne Yau, Courtney Reichhardt, Trevor Beaudoin, Stephanie O. Uwumarenogie +10 more
Travis B. Nielsen, Peggy Lu, Yuli Talyansky, Matt Slarve, Hernan Reza +9 more
Antonio DiGiandomenico, Vishnu Raghuram, Marc Schulman, Jennifer M. Scarff, Michael R. Davis +4 more
Antonio DiGiandomenico, Vishnu Raghuram, Marc Schulman, Jennifer M. Scarff, Michael R. Davis +4 more